The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Opioids Drug-Global Market Insights and Sales Trends 2025
Synopsis
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids Drug market size is expected to reach US$ 8836.3 million by 2029, growing at a CAGR of -1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Opioids Drug in various end use industries. The expanding demands from the Pain Relief, Anesthesia and Others,, are propelling Opioids Drug market. Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hydromorphone segment is estimated at % CAGR for the next seven-year period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioids Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioids Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioids Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioids Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioids Drug covered in this report include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
The global Opioids Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Global Opioids Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioids Drug market, Segment by Type:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Global Opioids Drug market, by Application
Pain Relief
Anesthesia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids Drug market size is expected to reach US$ 8836.3 million by 2029, growing at a CAGR of -1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Opioids Drug in various end use industries. The expanding demands from the Pain Relief, Anesthesia and Others,, are propelling Opioids Drug market. Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hydromorphone segment is estimated at % CAGR for the next seven-year period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioids Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioids Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioids Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioids Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioids Drug covered in this report include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
The global Opioids Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Global Opioids Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioids Drug market, Segment by Type:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Global Opioids Drug market, by Application
Pain Relief
Anesthesia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Opioids Drug Market Overview
1.1 Opioids Drug Product Overview
1.2 Opioids Drug Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.3 Global Opioids Drug Market Size by Type
1.3.1 Global Opioids Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Opioids Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Opioids Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Opioids Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Opioids Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Opioids Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Opioids Drug Sales Breakdown by Type (2018-2023)
2 Global Opioids Drug Market Competition by Company
2.1 Global Top Players by Opioids Drug Sales (2018-2023)
2.2 Global Top Players by Opioids Drug Revenue (2018-2023)
2.3 Global Top Players by Opioids Drug Price (2018-2023)
2.4 Global Top Manufacturers Opioids Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Drug Market Competitive Situation and Trends
2.5.1 Opioids Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Opioids Drug Market
2.8 Key Manufacturers Opioids Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Drug Status and Outlook by Region
3.1 Global Opioids Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Opioids Drug Historic Market Size by Region
3.2.1 Global Opioids Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Opioids Drug Sales in Value by Region (2018-2023)
3.2.3 Global Opioids Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Opioids Drug Forecasted Market Size by Region
3.3.1 Global Opioids Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Opioids Drug Sales in Value by Region (2024-2029)
3.3.3 Global Opioids Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Opioids Drug by Application
4.1 Opioids Drug Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Others
4.2 Global Opioids Drug Market Size by Application
4.2.1 Global Opioids Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Opioids Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Opioids Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Opioids Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Opioids Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Opioids Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Opioids Drug Sales Breakdown by Application (2018-2023)
5 North America Opioids Drug by Country
5.1 North America Opioids Drug Historic Market Size by Country
5.1.1 North America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Opioids Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Opioids Drug Sales in Value by Country (2018-2023)
5.2 North America Opioids Drug Forecasted Market Size by Country
5.2.1 North America Opioids Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Opioids Drug Sales in Value by Country (2024-2029)
6 Europe Opioids Drug by Country
6.1 Europe Opioids Drug Historic Market Size by Country
6.1.1 Europe Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Opioids Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Opioids Drug Sales in Value by Country (2018-2023)
6.2 Europe Opioids Drug Forecasted Market Size by Country
6.2.1 Europe Opioids Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Opioids Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Opioids Drug by Region
7.1 Asia-Pacific Opioids Drug Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Opioids Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Opioids Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Opioids Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Opioids Drug Sales in Value by Region (2024-2029)
8 Latin America Opioids Drug by Country
8.1 Latin America Opioids Drug Historic Market Size by Country
8.1.1 Latin America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Opioids Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Opioids Drug Sales in Value by Country (2018-2023)
8.2 Latin America Opioids Drug Forecasted Market Size by Country
8.2.1 Latin America Opioids Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Opioids Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Opioids Drug by Country
9.1 Middle East and Africa Opioids Drug Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Opioids Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Opioids Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Opioids Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Opioids Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Opioids Drug Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Company Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Purdue Pharma Opioids Drug Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mallinckrodt Opioids Drug Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Company Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amneal Pharma Opioids Drug Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Company Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Collegium Opioids Drug Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Company Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 J&J Opioids Drug Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Company Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Endo Opioids Drug Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Opioids Drug Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Company Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 INSYS Opioids Drug Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Opioids Drug Products Offered
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Company Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hikma Opioids Drug Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Company Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Egalet Opioids Drug Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Drug Industrial Chain Analysis
11.4 Opioids Drug Market Dynamics
11.4.1 Opioids Drug Industry Trends
11.4.2 Opioids Drug Market Drivers
11.4.3 Opioids Drug Market Challenges
11.4.4 Opioids Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Drug Distributors
12.3 Opioids Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
